Immunovia AB
0G8XStockLSE
0.18 ▼ 2.04%
Jun 10, 2026
0
Immunovia AB
0.18 ▼ 2.04%
Jun 10, 2026
0G8XStockLSE

About the company

Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.

Arberion
Loading market data